Related Experiment Video
Updated: Jul 22, 2026

Asymmetric Walkway: A Novel Behavioral Assay for Studying Asymmetric Locomotion
Published on: January 15, 2016
Basal Ganglia and Brainstem Located Cerebral Microbleeds Contributed to Gait Impairment in Patients with Cerebral
He-Jiao Mao1, Jiang-Xia Zhang1, Wen-Cheng Zhu2
1Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Background:
The mechanism of gait disorder in patients with cerebral small vessel disease (CSVD) remains unclear. Limited studies have compared the effect of cerebral microbleeds (CMBs) and lacunes on gait disturbance in CSVD patients in different anatomical locations.
Objective:
To investigate the relationship of quantitative gait parameters with varied anatomically located MRI imaging markers in patients with CSVD.
Methods:
Quantitative gait tests were performed on 127 symptomatic CSVD patients all with diffuse distributed white matter hyperintensities (WMHs). CMBs and lacunes in regard to anatomical locations and burdens were measured. The correlation between CSVD imaging markers and gait parameters was evaluated using general linear model analysis.
Results:
Presence of CMBs was significantly associated with stride length (β= -0.098, p = 0.0272) and right step length (β= -0.054, p = 0.0206). Presence of CMBs in basal ganglia (BG) was significantly associated with stride length and step length. Presence of CMBs in brainstem was significantly associated with gait parameters including stride length, step length, step height, and step width. Presence of lacunes in brainstem was significantly associated with gait speed (β= -0.197, p = 0.0365). However, presence of lacunes in the other areas was not associated with worse gait performances.
Conclusion:
BG and brain stem located CMBs contributed to gait impairment in symptomatic CSVD patients.
Insights
Cerebral microbleeds (CMBs) in the basal ganglia and brainstem significantly impact gait in cerebral small vessel disease (CSVD) patients, affecting stride and step length. Brainstem lacunes also correlate with reduced gait speed in these individuals.
Area of Science:
- Neurology
- Neuroimaging
- Gait Analysis
Background:
- Gait disorders in cerebral small vessel disease (CSVD) mechanisms are not fully understood.
- Limited research compares the impact of cerebral microbleeds (CMBs) and lacunes in different brain locations on CSVD gait disturbance.
Purpose of the Study:
- To investigate the relationship between quantitative gait parameters and anatomically located MRI markers in CSVD patients.
- To explore how CMBs and lacunes in specific brain regions influence gait.
Main Methods:
- 127 symptomatic CSVD patients with white matter hyperintensities underwent quantitative gait testing.
- Cerebral microbleeds (CMBs) and lacunes were assessed for location and burden.
- General linear models analyzed correlations between CSVD imaging markers and gait parameters.
Main Results:
- CMBs were linked to reduced stride length and step length.
- Basal ganglia CMBs correlated with stride and step length.
- Brainstem CMBs were associated with stride length, step length, step height, and step width.
- Brainstem lacunes correlated with slower gait speed; other lacunes showed no gait association.
Conclusions:
- Cerebral microbleeds (CMBs) located in the basal ganglia and brainstem significantly contribute to gait impairment in symptomatic CSVD patients.
- Brainstem lacunes are also associated with gait disturbances, specifically reduced gait speed.
Related Concept Videos
The Blood-brain Barrier
The Arch of Aorta
Encircling the heart, the coronary arteries form a ring-like structure before...
Arteries of the Head and Neck
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Cerebral Edema ll: Pathophysiology

